Cat. #162361
UNG Helix-mutant_1 CH12F3 cell line
Cat. #: 162361
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Organism: Mouse
Tissue: Blood
Disease: Lymphoma
Model: Mutant
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Bodil Merete Kavli
Institute: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: UNG Helix-mutant_1 CH12F3 cell line
- Cancer: Blood cancer
- Tool sub type: Continuous
- Organism: Mouse
- Tissue: Blood
- Disease: Lymphoma
- Model: Mutant
- Model description: UNG Helix-mutant_1 mutant using CRISPR-Cas9
- Crispr: Yes
- Description: Mouse B lymphocyte cell line expressing mutated UNG at helix level
- Biosafety level: 2
Target Details
- Target: UNG Helix-mutant_1 mutant
Handling
- Format: Frozen
- Passage number: Mouse B lymphocyte cell line UNG Helix-mutant_1 mutant using CRISPR-Cas9
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Cultured in antibiotics: Yes, penicillin/streptomycin
References
- Hayran et al., 2024. Nucleic Acids Res. 52(2):784-800, PMID: 38000394
